CENGİZ SEVAL, G. Et Al. 2020. Ibrutinib As a Promising Treatment for Heavily Pretreated Waldenström Macroglobulinemia: A Real World Data. 62th ASH Annual Meeting , (United States Of America).

CENGİZ SEVAL, G., İLHAN, O., FERHANOĞLU, A. B., ÇETİN, G., KURTOĞLU, E., ATALAY, F., ... NALÇACI, M.(2020). Ibrutinib As a Promising Treatment for Heavily Pretreated Waldenström Macroglobulinemia: A Real World Data . 62th ASH Annual Meeting, United States Of America

CENGİZ SEVAL, GÜLDANE Et Al. "Ibrutinib As a Promising Treatment for Heavily Pretreated Waldenström Macroglobulinemia: A Real World Data," 62th ASH Annual Meeting, United States Of America, 2020

CENGİZ SEVAL, GÜLDANE C. Et Al. "Ibrutinib As a Promising Treatment for Heavily Pretreated Waldenström Macroglobulinemia: A Real World Data." 62th ASH Annual Meeting , United States Of America, 2020

CENGİZ SEVAL, G. Et Al. (2020) . "Ibrutinib As a Promising Treatment for Heavily Pretreated Waldenström Macroglobulinemia: A Real World Data." 62th ASH Annual Meeting , United States Of America.

@conferencepaper{conferencepaper, author={GÜLDANE CENGİZ SEVAL Et Al. }, title={Ibrutinib As a Promising Treatment for Heavily Pretreated Waldenström Macroglobulinemia: A Real World Data}, congress name={62th ASH Annual Meeting}, city={}, country={United States Of America}, year={2020}}